Cellaura Pathlab(S) (Opc) Private Limited - Due diligence report

A 360° intelligence report on Cellaura Pathlab(S) (Opc) Private Limited: trust score, financial health, credit view, compliance, directors, …

2017-04-21 Bangalore North, Karnataka Active Unlisted Active Non-Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Cellaura Pathlab(S) (Opc) Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
67/100
Trust Score
Moderate

Cellaura Pathlab(S) (Opc) Private Limited is assessed as Moderate with a Trust Score of 67/100. Cellaura Pathlab(S) (Opc) Private Limited is an active company incorporated in 2017, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 28 Oct 2026 from the latest processed filings. Cellaura Pathlab(S) (Opc) Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
67/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
68/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
35/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
25/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 35/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 2 open (14.30 Lakh) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Canara Bank2 48.0 cr
Compliance Score: 68/100 Moderate
  • Company status is Active as per MCA.
  • Marked ACTIVE non-compliant (INC-22A).
  • Balance sheet slightly behind (Mar 2025).
05

Director Intelligence

Stability score: 25/100
NameDIN / PANDesignationAppointedTenureDIN status
PRAVEEN YADAV 01234567 Director 01/04/2018 6 yrs Approved
  • Board below statutory minimum.
  • PRAVEEN YADAV has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +2.1x over 3 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Asset base grew 61% - capacity expansion.
Net margin improved to 38%.
Operating for 9 years.
Distress signals & risk flags
Outside liabilities up 1.42 in a year.
2 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence71/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment57/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 14.30 Lakh already registered.
  • Compliance gaps should be priced into terms.
Investor view83/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 5 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 5 events
31 Mar 2025
Latest balance sheet
Filed with ROC
27 Apr 2023
Charge created
Canara Bank - 6.30 Lakh
Charge created
Canara Bank - 8.00 Lakh
21 Apr 2017
Incorporated
Registered with Roc Bangalore
Director appointed
PRAVEEN YADAV (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 3 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
1 active director(s) / partner(s); review board churn before relying on management continuity.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
P.S. Dental Centre Private Limited U93000TN2013PTC091905 Chennai, Tamil Nadu, India
Smile-N-Shine Orthodontic Care Private Limited U85100MH1987PTC042660 Pune, Maharashtra, India
Smile Zone Medident Private Limited U51397DL2008PTC185009 New Delhi, Delhi, India
Medimudra Private Limited U85110DL2021PTC386347 New Delhi, Delhi, India
Dr. Vijay'S Laxmi Dental Care Private Limited U85120TG2020PTC142872 Jagtial, Telangana, India
Magadh Diagnostic & Health Care Private Limited U74900BR2010PTC016233 Patna, Bihar, India
Arihant Dental Care Private Limited U85110MH2004PTC146261 Thane(W), Maharashtra, India
Vrk International Private Limited U74999DL2016PTC308277 Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Cellaura Pathlab(S) (Opc) Private Limited before audits and certifications: compliance score 68/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Cellaura Pathlab(S) (Opc) Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 35/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Cellaura Pathlab(S) (Opc) Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 67/100, distress signals and MSME payment-delay disclosures - know whether Cellaura Pathlab(S) (Opc) Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Cellaura Pathlab(S) (Opc) Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Cellaura Pathlab(S) (Opc) Private Limited an active company?

Cellaura Pathlab(S) (Opc) Private Limited has MCA status “Active” with a compliance score of 68/100 (Moderate).

Is Cellaura Pathlab(S) (Opc) Private Limited financially healthy?

Cellaura Pathlab(S) (Opc) Private Limited has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.

Should I do business with Cellaura Pathlab(S) (Opc) Private Limited?

Its overall Trust Score is 67/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Cellaura Pathlab(S) (Opc) Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 1 active director(s) are on record.

Does Cellaura Pathlab(S) (Opc) Private Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets.

Is Cellaura Pathlab(S) (Opc) Private Limited up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 68/100 (Moderate).

Is it risky to lend to Cellaura Pathlab(S) (Opc) Private Limited?

Its Credit Risk Score is 35/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.